BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, July 12, 2026
Home » Authors » Catherine Hollingsworth

Catherine Hollingsworth

Articles

ARTICLES

Pervasis, FDA Agree on Phase III as Partner Talks Advance

Feb. 2, 2010
By Catherine Hollingsworth

Gilead Earnings Rise on Atripla, Truvada Sales

Jan. 28, 2010
By Catherine Hollingsworth

Germany's Priaxon Getting up to $122M in Boehringer Cancer Deal

Jan. 27, 2010
By Catherine Hollingsworth

Keryx has Good Phase II Data for Perifosine in Colon Cancer

Jan. 26, 2010
By Catherine Hollingsworth

Achillion to Raise $19.7M to Bolster its Hepatitis Program

Jan. 25, 2010
By Catherine Hollingsworth

Elevation Pharma Hauls in $30M Series A to Fund COPD Studies

Jan. 22, 2010
By Catherine Hollingsworth

Lexicon Reports Positive Results from Phase II Diabetes Study

Jan. 21, 2010
By Catherine Hollingsworth

Germany's Priaxon Getting up to $122M in Boehringer Cancer Deal

Jan. 20, 2010
By Catherine Hollingsworth

NewCo News: JDP, with New CEO on Board, Goes for PC, Allergy Markets

Jan. 20, 2010
By Catherine Hollingsworth

BioInvent Plans to Raise $21M in Share Offering to Push Pipeline

Jan. 15, 2010
By Catherine Hollingsworth
Sweden's BioInvent International AB plans to raise SEK150 million (US$21M) by issuing 5.4 million new shares, money that could strengthen the company's position as it looks for new collaborations and opportunities to extend its pipeline. (BioWorld Today)
Read More
View All Articles by Catherine Hollingsworth

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 10, 2026.
  • 3D rendering of an antibody drug conjugate

    ‘Target-high but uptake-defective’ state identified in ADC resistance

    BioWorld
    Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
  • Wainua autoinjector

    Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy

    BioWorld
    News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
  • Art concept for medical research

    FENS 2026: Shedding light on the sheddome

    BioWorld
    At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
  • Silhouette with keyhole

    FENS 2026: Next-gen biologics take on brain disease

    BioWorld
    Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing